Sound Bioventures logo

Sound Bioventures

Europe, Skane Lan, Sweden, Malmö

Description

Sound Bioventures is a venture capital fund investing in clinical stage companies.

Investor Profile

Sound Bioventures has backed more than 9 startups, with 2 new investments in the last 12 months alone. The firm has led 7 rounds, about 78% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, The Netherlands.
  • Strong thematic focus on Biotechnology, Biopharma, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (33%)
  • Series Unknown (22%)
  • Series B (22%)
  • Convertible Note (11%)
  • Seed (11%)

Country Focus

  • United States (33%)
  • United Kingdom (11%)
  • The Netherlands (11%)
  • Spain (11%)
  • Denmark (11%)
  • France (11%)
  • Sweden (11%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Therapeutics
  • Medical
  • Health Care
  • Manufacturing
  • Pharmaceutical
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sound Bioventures frequently co-invest with?

Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Columbus Venture Partners
Europe, Madrid, Spain, Madrid
Co-Investments: 3
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 2
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 1
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 1

Which angels does Sound Bioventures often collaborate with?

BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 2
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Sound Bioventures?

AnaCardio

Solna, Stockholms Lan, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

BiopharmaBiotechnologyMedical
Series AJan 9, 2025
Amount Raised: $18,379,535
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Convertible NoteAug 6, 2024
Amount Raised: $8,000,000
Theolytics

Oxford, Oxfordshire, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

BiotechnologyMedicalTherapeutics
Series UnknownApr 17, 2024
Amount Raised: $23,660,858
AbolerIS Pharma

Nantes, Pays de la Loire, France

AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.

Biotechnology
Series ASep 19, 2023
Amount Raised: $29,160,405
VarmX

Leiden, Zuid-Holland, The Netherlands

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

ManufacturingPharmaceuticalTherapeutics
Series BMay 25, 2023
Amount Raised: $36,950,090
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BMay 3, 2023
Amount Raised: $46,487,689
Teitur Trophics

Aarhus, Midtjylland, Denmark

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

BiotechnologyLife ScienceMedical
Series AMar 14, 2023
Amount Raised: $30,034,765
Breye Therapeutics

Denmark, South Carolina, United States

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

BiopharmaMedical
SeedNov 10, 2022
Amount Raised: $4,076,741
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownMay 11, 2022
Amount Raised: $26,000,000